Meta-analysis of comparative diagnostic performance of magnetic resonance imaging and multislice computed tomography for noninvasive coronary angiography. Am Heart J. 2006;151:404 11. 165. Stein PD, Beemath A, Kayali F, et al. Multidetector computed tomography for the diagnosis of coronary artery disease: a systematic review. Am J Med. 2006;119:203 16. 166. Sun Z, Jiang W. Diagnostic value of multislice computed tomography angiography in coronary artery disease: a meta-analysis. Eur J Radiol. 2006;60:279 86. 167. Underwood SR, Godman B, Salyani S, et al. Economics of myocardial perfusion imaging in Europe the EMPIRE Study. Eur Heart J. 1999; 20:157 66. 168. Nucifora G, Schuijf JD, van Werkhoven JM, et al. Relationship between obstructive coronary artery disease and abnormal stress testing in patients with paroxysmal or persistent atrial fibrillation. Int J Car- diovasc Imaging. 2011;27:777 85. 169. Greenwood JP, Maredia N, Younger JF, et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet. 2012;379:453 60. 170. Hundley WG, Hamilton CA, Thomas MS, et al. Utility of fast cine magnetic resonance imaging and display for the detection of myo- cardial ischemia in patients not well suited for second harmonic stress echocardiography. Circulation. 1999;100:1697 702. 171. Nagel E, Lehmkuhl HB, Bocksch W, et al. Noninvasive diagnosis of ischemia-induced wall motion abnormalities with the use of high-dose dobutamine stress MRI: comparison with dobutamine stress echocar- diography. Circulation. 1999;99:763 70. 172. Schwitter J, Wacker CM, van Rossum AC, et al. MR-IMPACT: com- parison of perfusion-cardiac magnetic resonance with singlephoton emission computed tomography for the detection of coronary artery disease in a multicentre, multivendor, randomized trial. Eur Heart J. 2008;29:480 9. 173. de Azevedo CF, Hadlich MS, Bezerra SG, et al. Prognostic value of CT angiography in patients with inconclusive functional stress tests. J Am Coll Cardiol Cardiovasc Imaging. 2011;4:740 51. 174. Sarwar A, Shaw LJ, Shapiro MD, et al. Diagnostic and prognostic value of absence of coronary artery calcification. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:675 88. 175. Mieres JH, Shaw LJ, Arai A, et al. Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. Circulation. 2005;111:682 96. 176. Nieman K, Galema TW, Neefjes LA, et al. Comparison of the value of coronary calcium detection to computed tomographic angiography and exercise testing in patients with chest pain. Am J Cardiol. 2009;104: 1499 504. 177. Alexander KP, Shaw LJ, Shaw LK, et al. Value of exercise treadmill testing in women. J Am Coll Cardiol. 1998;32:1657 64. 178. Daugherty SL, Magid DJ, Kikla JR, et al. Gender differences in the prognostic value of exercise treadmill test characteristics. Am Heart J. 2011;161:908 14. 179. Ovrehus KA, Jensen JK, Mickley HF, et al. Comparison of usefulness of exercise testing versus coronary computed tomographic angiography for evaluation of patients suspected of having coronary artery disease. Am J Cardiol. 2010;105:773 9. 180. Shaw LJ, Peterson ED, Shaw LK, et al. Use of a prognostic treadmill score in identifying diagnostic coronary disease subgroups. Circu- lation. 1998;98:1622 30. 181. Mulvagh SL, DeMaria AN, Feinstein SB, et al. Contrast echocardiog- raphy: current and future applications. J Am Soc Echocardiogr. 2000; 13:331 42. 182. Abdelmoneim SS, Bernier M, Dhoble A, et al. Assessment of myo- cardial perfusion during adenosine stress using real time threedimen- sional and two-dimensional myocardial contrast echocardiography: comparison with single-photon emission computed tomography. Echo- cardiography. 2010;27:421 9. 183. Berman D, Hachamovitch R, Shaw L, et al. Nuclear Cardiology. In: Fuster V, Alexander RW, O Rourke RA, et al., eds. Hurst s The Heart, 11th ed. New York: The McGraw-Hill Companies, Inc.; 2004: 563 98; 2004. 184. Fukushima K, Javadi MS, Higuchi T, et al. Prediction of short-term cardiovascular events using quantification of global myocardial flow reserve in patients referred for clinical 82Rb PET perfusion imaging. J Nucl Med. 2011;52:726 32. 185. El Fakhri G, Kardan A, Sitek A, et al. Reproducibility and accuracy of quantitative myocardial blood flow assessment with (82)Rb PET: com- parison with (13)N-ammonia PET. J Nucl Med. 2009;50:1062 71. 186. Yoshinaga K, Katoh C, Manabe O, et al. Incremental Diagnostic Value of Regional Myocardial Blood Flow Quantification Over Relative Perfusion Imaging With Generator-Produced Rubidium-82 PET. Circ J. 2011;75:2628 34. 187. Duvall WL, Sweeny J, Croft LB, et al. SPECT myocardial perfusion imaging in morbidly obese patients: image quality, hemodynamic response to pharmacologic stress, and diagnostic and prognostic value. J Nucl Cardiol. 2006;13:202 9. 188. Berman DS, Kang X, Nishina H, et al. Diagnostic accuracy of gated Tc-99m sestamibi stress myocardial perfusion SPECT with combined supine and prone acquisitions to detect coronary artery disease in obese and nonobese patients. J Nucl Cardiol. 2006;13:191 201. 189. Slomka PJ, Nishina H, Abidov A, et al. Combined quantitative supine-prone myocardial perfusion SPECT improves detection of coronary artery disease and normalcy rates in women. J Nucl Cardiol. 2007;14:44 52. 190. Pazhenkottil AP, Ghadri J-R, Nkoulou RN, et al. Improved outcome prediction by SPECT myocardial perfusion imaging after CT atten- uation correction. J Nucl Med. 2011;52:196 200. 191. Sampson UK, Dorbala S, Limaye A, et al. Diagnostic accuracy of rubidium-82 myocardial perfusion imaging with hybrid positron emission tomography/computed tomography in the detection of coronary artery disease. J Am Coll Cardiol. 2007;49:1052 8. 192. Nandalur KR, Dwamena BA, Choudhri AF, et al. Diagnostic per- formance of positron emission tomography in the detection of coronary artery disease: a meta-analysis. Acad Radiol. 2008;15:444 51. 193. Bateman TM, Heller GV, McGhie AI, et al. Diagnostic accuracy of rest/stress ECG-gated Rb-82 myocardial perfusion PET: comparison with ECG-gated Tc-99m sestamibi SPECT. J Nucl Cardiol. 2006;13: 24 33. 194. Pilz G, Eierle S, Heer T, et al. Negative predictive value of normal adenosine-stress cardiac MRI in the assessment of coronary artery disease and correlation with semiquantitative perfusion analysis. J Magn Reson Imaging. 2010;32:615 21. 195. Koo B-K, Erglis A, Doh J-H, et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms. Results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia- Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol. 2011;58:1989 97. 196. George RT, Arbab-Zadeh A, Cerci RJ, et al. Diagnostic performance of combined noninvasive coronary angiography and myocardial perfusion imaging using 320-MDCT: the CT angiography and perfusion methods Fihn et al Stable Ischemic Heart Disease: Full Text e439 of the CORE320 multicenter multinational diagnostic study. AJR Am J Roentgenol. 2011;197:829 37. 197. Valdiviezo C, Ambrose M, Mehra V, et al. Quantitative and qualitative analysis and interpretation of CT perfusion imaging. J Nucl Cardiol. 2010;17:1091 100. 198. Feuchtner G, Goetti R, Plass A, et al. Adenosine stress high-pitch 128-slice dual-source myocardial computed tomography perfusion for imaging of reversible myocardial ischemia: comparison with magnetic resonance imaging. Circ Cardiovasc Imaging. 2011;4:540 9. 199. Cury RC, Magalhaes TA, Borges AC, et al. Dipyridamole stress and rest myocardial perfusion by 64-detector row computed tomography in patients with suspected coronary artery disease. Am J Cardiol. 2010; 106:310 5. 200. Rocha-Filho JA, Blankstein R, Shturman LD, et al. Incremental value of adenosine-induced stress myocardial perfusion imaging with dual- source CT at cardiac CT angiography. Radiology. 2010;254:410 9. 201. Blankstein R, Shturman LD, Rogers IS, et al. Adenosine-induced stress myocardial perfusion imaging using dual-source cardiac computed tomography. J Am Coll Cardiol. 2009;54:1072 84. 202. van Werkhoven JM, Schuijf JD, Gaemperli O, et al. Prognostic value of multislice computed tomography and gated single-photon emission computed tomography in patients with suspected coronary artery disease. J Am Coll Cardiol. 2009;53:623 32. 203. Hachamovitch R, Di Carli MF. Nuclear cardiology will remain the gatekeeper over CT angiography. J Nucl Cardiol. 2007;14:634 44. 204. Di Carli MF, Dorbala S, Curillova Z, et al. Relationship between CT coronary angiography and stress perfusion imaging in patients with suspected ischemic heart disease assessed by integrated PET-CT imaging. J Nucl Cardiol. 2007;14:799 809. 205. Pazhenkottil AP, Husmann L, Kaufmann PA. Cardiac hybrid imaging with high-speed single-photon emission computed tomography/CT camera to detect ischaemia and coronary artery obstruction. Heart. 2010;96:2050. 206. Pazhenkottil AP, Nkoulou RN, Ghadri J-R, et al. Prognostic value of cardiac hybrid imaging integrating single-photon emission computed tomography with coronary computed tomography angiography. Eur Heart J. 2011;32:1465 71. 207. van Velzen JE, Schuijf JD, van Werkhoven JM, et al. Predictive value of multislice computed tomography variables of atherosclerosis for ischemia on stress-rest single-photon emission computed tomography. Circ Cardiovasc Imaging. 2010;3:718 26. 208. Min JK, Shaw LJ, Berman DS. The present state of coronary computed tomography angiography a process in evolution. J Am Coll Cardiol. 2010;55:957 65. 209. Mark DB, Berman DS, Budoff MJ, et al. ACCF/ACR/AHA/NASCI/ SAIP/SCAI/SCCT 2010 expert consensus document on coronary computed tomographic angiography: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Doc- uments. Circulation. 2010;121:2509 43. 210. Pundziute G, Schuijf JD, Jukema JW, et al. Gender influence on the diagnostic accuracy of 64-slice multislice computed tomography coronary angiography for detection of obstructive coronary artery disease. Heart. 2008;94:48 52. 211. Motoyama S, Sarai M, Harigaya H, et al. Computed tomographic angiography characteristics of atherosclerotic plaques subsequently resulting in acute coronary syndrome. J Am Coll Cardiol. 2009;54: 49 57. 212. Shaw LJ, Min JK, Narula J, et al. Sex differences in mortality asso- ciated with computed tomographic angiographic measurements of obstructive and nonobstructive coronary artery disease: an exploratory analysis. Circ Cardiovasc Imaging. 2010;3:473 81. 213. Motoyama S, Kondo T, Sarai M, et al. Multislice computed tomo- graphic characteristics of coronary lesions in acute coronary syn- dromes. J Am Coll Cardiol. 2007;50:319 26. 214. Villines TC, Hulten EA, Shaw LJ, et al. Prevalence and Severity of Coronary Artery Disease and Adverse Events Among Symptomatic Patients With Coronary Artery Calcification Scores of Zero Undergoing Coronary Computed Tomography Angiography: Results From the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) Registry. J Am Coll Cardiol. 2011;58:2540. 215. Shmilovich H, Cheng VY, Tamarappoo BK, et al. Vulnerable plaque features on coronary CT angiography as markers of inducible regional myocardial hypoperfusion from severe coronary artery stenoses. Ath- erosclerosis. 2011;219:588 95. 216. Lin FY, Shaw LJ, Dunning AM, et al. Mortality risk in symptomatic patients with nonobstructive coronary artery disease: a prospective 2-center study of 2,583 patients undergoing 64-detector row coronary computed tomographic angiography. J Am Coll Cardiol. 2011;58: 510 9. 217. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827 32. 218. O Rourke RA, Brundage BH, Froelicher VF, et al. American College of Cardiology/American Heart Association expert consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. J Am Coll Cardiol. 2000;32: 326 40. 219. Akram K, O Donnell RE, King S, et al. Influence of symptomatic status on the prevalence of obstructive coronary artery disease in patients with zero calcium score. Atherosclerosis. 2009;203:533 7. 220. Cademartiri F, Maffei E, Palumbo A, et al. Diagnostic accuracy of computed tomography coronary angiography in patients with a zero calcium score. Eur Radiol. 2010;20:81 7. 221. Haberl R, Tittus J, Bohme E, et al. Multislice spiral computed tomo- graphic angiography of coronary arteries in patients with suspected coronary artery disease: an effective filter before catheter angiography? Am Heart J. 2005;149:1112 9. 222. Henneman MM, Schuijf JD, Pundziute G, et al. Noninvasive eval- uation with multislice computed tomography in suspected acute coronary syndrome: plaque morphology on multislice computed tomography versus coronary calcium score. J Am Coll Cardiol. 2008; 52:216 22. 223. Rubinshtein R, Gaspar T, Halon DA, et al. Prevalence and extent of obstructive coronary artery disease in patients with zero or low calcium score undergoing 64-slice cardiac multidetector computed tomography for evaluation of a chest pain syndrome. Am J Cardiol. 2007;99:472 5. 224. Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report. Eur Heart J. 2004;25:1940 65. 225. Kim WY, Danias PG, Stuber M, et al. Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med. 2001;345:1863 9. 226. Danias PG, Roussakis A, Ioannidis JP. Diagnostic performance of coronary magnetic resonance angiography as compared against con- ventional X-ray angiography: a meta-analysis. J Am Coll Cardiol. 2004;44:1867 76. 227. Sakuma H. Coronary CT versus MR angiography: the role of MR angiography. Radiology. 2011;258:340 9. 228. Hamdan A, Asbach P, Wellnhofer E, et al. A prospective study for comparison of MR and CT imaging for detection of coronary artery stenosis. J Am Coll Cardiol Cardiovasc Imaging. 2011;4:50 61. 229. Buckley BS, Simpson CR, McLernon DJ, et al. Five year prognosis in patients with angina identified in primary care: incident cohort study. BMJ. 2009;339:b3058. 230. Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortality following acute coronary syndromes. JAMA. 2007;298:765 75. 231. Weiner DE, Tighiouart H, Stark PC, et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis. 2004;44:198 206. 232. Sachdev M, Sun JL, Tsiatis AA, et al. The prognostic importance of comorbidity for mortality in patients with stable coronary artery disease. J Am Coll Cardiol. 2004;43:576 82. 233. Hlatky MA. Comorbidity and outcome in patients with coronary artery disease. J Am Coll Cardiol. 2004;43:583 4. 234. Chirinos JA, Veerani A, Zambrano JP, et al. Evaluation of comorbidity scores to predict all-cause mortality in patients with established coronary artery disease. Int J Cardiol. 2007;117:97 102. 235. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192 217. 236. Denollet J, Pedersen SS, Vrints CJ, et al. Usefulness of type D per- sonality in predicting five-year cardiac events above and beyond con- current symptoms of stress in patients with coronary heart disease. Am J Cardiol. 2006;97:970 3. 237. Berkman LF, Blumenthal J, Burg M, et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial. JAMA. 2003;289: 3106 16. 238. Glassman AH, O Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701 9. 239. Ruo B, Rumsfeld JS, Hlatky MA, et al. Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA. 2003; 290:215 21. 240. Rumsfeld JS, Magid DJ, Plomondon ME, et al. History of depression, angina, and quality of life after acute coronary syndromes. Am Heart J. 2003;145:493 9. 241. Rumsfeld JS, Jones PG, Whooley MA, et al. Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J. 2005;150:961 7. 242. Rumsfeld JS, Ho PM. Depression and cardiovascular disease: a call for recognition. Circulation. 2005;111:250 3. 243. Rutledge T, Reis SE, Olson M, et al. Social networks are associated with lower mortality rates among women with suspected coronary disease: the National Heart, Lung, and Blood Institute-Sponsored Women s Ischemia Syndrome Evaluation study. Psychosom Med. 2004;66:882 8. 244. Horne BD, Muhlestein JB, Lappe DL, et al. Less affluent area of residence and lesser-insured status predict an increased risk of death or myocardial infarction after angiographic diagnosis of coronary disease. Ann Epidemiol. 2004;14:143 50. 245. Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case- control study. Lancet. 2004;364:953 62. 246. Spertus JA, Jones P, McDonell M, et al. Health status predicts long-term outcome in outpatients with coronary disease. Circulation. 2002;106:43 9. 247. Mozaffarian D, Bryson CL, Spertus JA, et al. Anginal symptoms consistently predict total mortality among outpatients with coronary artery disease. Am Heart J. 2003;146:1015 22. 248. Lauer MS, Pothier CE, Magid DJ, et al. An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electro- cardiogram. Ann Intern Med. 2007;147:821 8. 249. Hubbard BL, Gibbons RJ, Lapeyre AC III, et al. Identification of severe coronary artery disease using simple clinical parameters. Arch Intern Med. 1992;152:309 12. 250. Ho K-T, Miller TD, Hodge DO, et al. Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease. Mayo Clin Proc. 2002;77:515 21. 251. Miller TD, Roger VL, Hodge DO, et al. A simple clinical score accurately predicts outcome in a community-based population undergoing stress testing. Am J Med. 2005;118:866 72. 252. Diamond GA, Kaul S. COURAGE under fire: on the management of stable coronary disease. J Am Coll Cardiol. 2007;50:1604 9. 253. Buckley DI, Fu R, Freeman M, et al. C-reactive protein as a risk factor for coronary heart disease: a systematic review and metaanalyses for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151: 483 95. 254. Oremus M, Raina PS, Santaguida P, et al. A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease. Clin Biochem. 2008;41:260 5. 255. Shah T, Casas JP, Cooper JA, et al. Critical appraisal of CRP mea- surement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts. Int J Epidemiol. 2009;38:217 31. 256. Heslop CL, Frohlich JJ, Hill JS. Myeloperoxidase and C-reactive protein have combined utility for long-term prediction of cardiovascu- lar mortality after coronary angiography. J Am Coll Cardiol. 2010;55: 1102 9. 257. Grundy SM, Cleeman JI, Daniels SR, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005;112:2735 52. 258. O Donoghue M, Morrow DA, Sabatine MS, et al. Lipoproteinasso- ciated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 (PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. Circulation. 2006;113:1745 52. 259. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation. 2006;113:1071 8. 260. Mock MB, Ringqvist I, Fisher LD, et al. Survival of medically treated patients in the coronary artery surgery study (CASS) registry. Circu- lation. 1982;66:562 8. 261. Vitarelli A, Tiukinhoy S, Di Luzio S, et al. The role of echocardiog- raphy in the diagnosis and management of heart failure. Heart Fail Rev. 2003;8:181 9. 262. Levy D, Garrison RJ, Savage DD, et al. Left ventricular mass and incidence of coronary heart disease in an elderly cohort. The Fra- mingham Heart Study. Ann Intern Med. 1989;110:101 7. 263. Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the Fra- mingham Heart Study. N Engl J Med. 1990;322:1561 6. 264. Nagao T, Chikamori T, Hida S, et al. Quantitative gated singlephoton emission computed tomography with (99m)Tc sestamibi predicts major cardiac events in elderly patients with known or suspected coronary artery disease: the QGS-Prognostic Value in the Elderly (Q-PROVE) Study. Circ J. 2007;71:1029 34. 265. Leischik R, Dworrak B, Littwitz H, et al. Prognostic significance of exercise stress echocardiography in 3329 outpatients (5-year longi- tudinal study). Int J Cardiol. 2007;119:297 305. 266. Johansen A, Hoilund-Carlsen PF, Vach W, et al. Prognostic value of myocardial perfusion imaging in patients with known or suspected stable angina pectoris: evaluation in a setting in which myocardial perfusion imaging did not influence the choice of treatment. Clin Physiol Funct Imaging. 2006;26:288 95. 267. Badran HM, Elnoamany MF, Seteha M. Tissue velocity imaging with dobutamine stress echocardiography a quantitative technique for identification of coronary artery disease in patients with left bundle branch block. J Am Soc Echocardiogr. 2007;20:820 31. 268. Bello D, Shah DJ, Farah GM, et al. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy. Circulation. 2003;108:1945 53. 269. Epstein FH. MRI of left ventricular function. J Nucl Cardiol. 2007;14: 729 44. 270. Wagdy HM, Hodge D, Christian TF, et al. Prognostic value of vaso- dilator myocardial perfusion imaging in patients with left bundle- branch block. Circulation. 1998;97:1563 70. 271. Bouzas-Mosquera A, Peteiro J, Alvarez-Garcia N, et al. Prediction of mortality and major cardiac events by exercise echocardiography in patients with normal exercise electrocardiographic testing. J Am Coll Cardiol. 2009;53:1981 90. 272. Navare SM, Mather JF, Shaw LJ, et al. Comparison of risk stratifi- cation with pharmacologic and exercise stress myocardial perfusion imaging: a meta-analysis. J Nucl Cardiol. 2004;11:551 61. 273. Gebker R, Jahnke C, Manka R, et al. The role of dobutamine stress cardiovascular magnetic resonance in the clinical management of patients with suspected and known coronary artery disease. J Car- diovasc Magn Reson. 2011;13:46. 274. Peteiro J, Bouzas-Mosquera A, Broullon FJ, et al. Prognostic value of peak and post-exercise treadmill exercise echocardiography in patients with known or suspected coronary artery disease. Eur Heart J. 2010; 31:187 95. 275. Yao SS, Wever-Pinzon O, Zhang X, et al. Prognostic value of stress echocardiogram in patients with angiographically significant coronary artery disease. Am J Cardiol. 2012;109:153 8. 276. Shaw L, Cerqueira M, Brooks M, et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocaridal perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascuarization Investigation 2 Diabetes (BARI 2D) Trial. J Nucl Cardiol. 2012. 277. Hachamovitch R, Rozanski A, Shaw LJ, et al. Impact of ischaemia and scar on the therapeutic benefit derived from myocardial revasculariza- tion vs. medical therapy among patients undergoing stress-rest myo- cardial perfusion scintigraphy. Eur Heart J. 2011;32:1012 24. 278. Doesch C, Seeger A, Doering J, et al. Risk stratification by adenosine stress cardiac magnetic resonance in patients with coronary artery stenoses of intermediate angiographic severity. J Am Coll Cardiol Cardiovasc Imaging. 2009;2:424 33. Fihn et al Stable Ischemic Heart Disease: Full Text e441 279. Jahnke C, Nagel E, Gebker R, et al. Prognostic value of cardiac magnetic resonance stress tests: adenosine stress perfusion and dobu- tamine stress wall motion imaging. Circulation. 2007;115:1769 76. 280. Bingham SE, Hachamovitch R. Incremental prognostic significance of combined cardiac magnetic resonance imaging, adenosine stress per- fusion, delayed enhancement, and left ventricular function over pre- imaging information for the prediction of adverse events. Circulation. 2011;123:1509 18. 281. Coelho-Filho OR, Seabra LF, Mongeon F-P. Stress Myocardial Per- fusion Imaging by CMR Provides Strong Prognostic Value to Cardiac Events Regardless of Patient s Sex. J Am Coll Cardiol Cardiovasc Imaging. 2011;4:850 61. 282. Kelle S, Chiribiri A, Vierecke J, et al. Long-term prognostic value of dobutamine stress CMR. J Am Coll Cardiol Cardiovasc Imaging. 2011;4:161 72. 283. Korosoglou G, Elhmidi Y, Steen H, et al. Prognostic value of high-dose dobutamine stress magnetic resonance imaging in 1493 consecutive patients: assessment of myocardial wall motion and perfusion. J Am Coll Cardiol. 2010;56:1225 34. 284. Steel K, Broderick R, Gandla V, et al. Complementary prognostic values of stress myocardial perfusion and late gadolinium enhancement imaging by cardiac magnetic resonance in patients with known or suspected coronary artery disease. Circulation. 2009;120:1390 400. 285. Chow BJW, Wells GA, Chen L, et al. Prognostic value of 64-slice cardiac computed tomography severity of coronary artery disease, coronary atherosclerosis, and left ventricular ejection fraction. J Am Coll Cardiol. 2010;55:1017 28. 286. Min JK, Dunning A, Lin FY, et al. Age- and Sex-Related Differences in All-Cause Mortality Risk Based on Coronary Computed Tomography Angiography Findings Results From the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23 854 Patients Without Known Coronary Artery Disease. J Am Coll Cardiol. 2011;58:849 60. 287. America YGCJ, Bax JJ, Boersma E, et al. Prognostic value of gated SPECT in patients with left bundle branch block. J Nucl Cardiol. 2007;14:75 81. 288. Gil VM, Almeida M, Ventosa A, et al. Prognosis in patients with left bundle branch block and normal dipyridamole thallium-201 scintigra- phy. J Nucl Cardiol. 1998;5:414 7. 289. Nallamothu N, Bagheri B, Acio ER, et al. Prognostic value of stress myocardial perfusion single photon emission computed tomography imaging in patients with left ventricular bundle branch block. J Nucl Cardiol. 1997;4:487 93. 290. Nigam A, Humen DP. Prognostic value of myocardial perfusion imaging with exercise and/or dipyridamole hyperemia in patients with preexisting left bundle branch block. J Nucl Med. 1998;39:579 81. 291. Pilz G, Jeske A, Klos M, et al. Prognostic value of normal adenosine- stress cardiac magnetic resonance imaging. Am J Cardiol. 2008;101: 1408 12. 292. Tandogan I, Yetkin E, Yanik A, et al. Comparison of thallium-201 exercise SPECT and dobutamine stress echocardiography for diagnosis of coronary artery disease in patients with left bundle branch block. Int J Cardiovasc Imaging. 2001;17:339 45. 293. Hacker M, Jakobs T, Hack N, et al. Combined use of 64-slice computed tomography angiography and gated myocardial perfusion SPECT for the detection of functionally relevant coronary artery ste- noses. First results in a clinical setting concerning patients with stable angina. Nuklearmedizin. 2007;46:29 35. 294. Yao SS, Bangalore S, Chaudhry FA. Prognostic implications of stress echocardiography and impact on patient outcomes: an effective gate- keeper for coronary angiography and revascularization. J Am Soc Echocardiogr. 2010;23:832 9. 295. Braunwald E, Domanski MJ, Fowler SE, et al. Angiotensinconverting- enzyme inhibition in stable coronary artery disease. N Engl J Med. 2004;351:2058 68. 296. Fox KM. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet. 2003;362:782 8. 297. Garg R, Yusuf S. Overview of randomized trials of angioten- sinconverting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA. 1995;273:1450 6. 298. Kunz R, Friedrich C, Wolbers M, et al. Meta-analysis: effect of mono- therapy and combination therapy with inhibitors of the renin angioten- sin system on proteinuria in renal disease. Ann Intern Med. 2008;148: 30 48. 299. McCully RB, Roger VL, Mahoney DW, et al. Outcome after abnormal exercise echocardiography for patients with good exercise capacity: prognostic importance of the extent and severity of exercise-related left ventricular dysfunction. J Am Coll Cardiol. 2002;39:1345 52. 300. Shaw LJ, Hendel R, Borges-Neto S, et al. Prognostic value of normal exercise and adenosine (99m)Tc-tetrofosmin SPECT imaging: results from the multicenter registry of 4728 patients. J Nucl Med. 2003;44: 134 9. 301. Yusuf S, Sleight P, Pogue J, et al. Effects of an angiotensinconverting- enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investi- gators. N Engl J Med. 2000;342:145 53. 302. Weiner DA, Ryan TJ, McCabe CH, et al. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease. J Am Coll Cardiol. 1984;3:772 9. 303. Cole CR, Blackstone EH, Pashkow FJ, et al. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341:1351 7. 304. McCully RB, Roger VL, Mahoney DW, et al. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol. 1998;31:144 9. 305. Hachamovitch R, Rozanski A, Hayes SW, et al. Predicting therapeutic benefit from myocardial revascularization procedures: are mea- surements of both resting left ventricular ejection fraction and stress- induced myocardial ischemia necessary? J Nucl Cardiol. 2006;13: 768 78. 306. Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic bur- den: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117:1283 91. 307. Hachamovitch R, Hayes S, Friedman JD, et al. Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan? J Am Coll Cardiol. 2003;41:1329 40. 308. Chaowalit N, McCully RB, Callahan MJ, et al. Outcomes after normal dobutamine stress echocardiography and predictors of adverse events: long-term follow-up of 3014 patients. Eur Heart J. 2006;27:3039 44. 309. Elhendy A, Mahoney DW, Khandheria BK, et al. Prognostic signif- icance of the location of wall motion abnormalities during exercise echocardiography. J Am Coll Cardiol. 2002;40:1623 9. 310. Hachamovitch R, Berman DS, Shaw LJ, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratifi- cation for risk of cardiac death and myocardial infarction. Circulation. 1998;97:535 43. 311. Marwick TH, Case C, Vasey C, et al. Prediction of mortality by exercise echocardiography: a strategy for combination with the Duke treadmill score. Circulation. 2001;103:2566 71. 312. Marwick TH, Case C, Sawada S, et al. Prediction of mortality using dobutamine echocardiography. J Am Coll Cardiol. 2001;37:754 60. 313. Shaw LJ, Hachamovitch R, Heller GV, et al. Noninvasive strategies for the estimation of cardiac risk in stable chest pain patients. The Eco- nomics of Noninvasive Diagnosis (END) Study Group. Am J Cardiol. 2000;86:1 7. 314. Shaw LJ, Hendel RC, Cerquiera M, et al. Ethnic differences in the prognostic value of stress technetium-99m tetrofosmin gated single- photon emission computed tomography myocardial perfusion imaging. J Am Coll Cardiol. 2005;45:1494 504. 315. Shaw LJ, Vasey C, Sawada S, et al. Impact of gender on risk stratifi- cation by exercise and dobutamine stress echocardiography: long-term mortality in 4234 women and 6898 men. Eur Heart J. 2005;26:447 56. 316. Gibbons RJ, Hodge DO, Berman DS, et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circu- lation. 1999;100:2140 5. 317. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation. 1996;93:905 14. 318. Levy D, Salomon M, D Agostino RB, et al. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation. 1994;90: 1786 93. 319. Poornima IG, Miller TD, Christian TF, et al. Utility of myocardial perfusion imaging in patients with low-risk treadmill scores. J Am Coll Cardiol. 2004;43:194 9. 320. Hachamovitch R, Hayes SW, Friedman JD, et al. A prognostic score for prediction of cardiac mortality risk after adenosine stress myo- cardial perfusion scintigraphy. J Am Coll Cardiol. 2005;45:722 9. 321. America YG, Bax JJ, Boersma E, et al. The additive prognostic value of perfusion and functional data assessed by quantitative gated SPECT in women. J Nucl Cardiol. 2009;16:10 9. 322. Sharir T, Kang X, Germano G, et al. Prognostic value of poststress left ventricular volume and ejection fraction by gated myocardial perfusion SPECT in women and men: gender-related differences in normal limits and outcomes. J Nucl Cardiol. 2006;13:495 506. 323. Yoshinaga K, Chow BJ, Williams K, et al. What is the prognostic value of myocardial perfusion imaging using rubidium-82 positron emission tomography? J Am Coll Cardiol. 2006;48:1029 39. 324. Yao SS, Qureshi E, Sherrid MV, et al. Practical applications in stress echocardiography: risk stratification and prognosis in patients with known or suspected ischemic heart disease. J Am Coll Cardiol. 2003; 42:1084 90. 325. Lertsburapa K, Ahlberg AW, Bateman TM, et al. Independent and incremental prognostic value of left ventricular ejection fraction determined by stress gated rubidium 82 PET imaging in patients with known or suspected coronary artery disease. J Nucl Cardiol. 2008;15: 745 53. 326. Hachamovitch R. Risk assessment of patients with known or suspected CAD using stress myocardial perfusion SPECT. Part I: The ongoing evolution of clinical evidence. Rev Cardiovasc Med. 2000;1:91 102. 327. Hachamovitch R, Hayes SW, Friedman JD, et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900 7. 328. Gehi AK, Ali S, Na B, et al. Inducible ischemia and the risk of recurrent cardiovascular events in outpatients with stable coronary heart disease: the heart and soul study. Arch Intern Med. 2008;168: 1423 8. 329. Bodi V, Sanchis J, Lopez-Lereu MP, et al. Prognostic value of dipyr- idamole stress cardiovascular magnetic resonance imaging in patients with known or suspected coronary artery disease. J Am Coll Cardiol. 2007;50:1174 9. 330. Bangalore S, Yao SS, Chaudhry FA. Usefulness of stress echocardi- ography for risk stratification and prognosis of patients with left ven- tricular hypertrophy. Am J Cardiol. 2007;100:536 43. 331. Sharir T, Germano G, Kavanagh PB, et al. Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation. 1999;100:1035 42. 332. Abidov A, Bax JJ, Hayes SW, et al. Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT. J Am Coll Cardiol. 2003;42:1818 25. 333. Parisi AF, Hartigan PM, Folland ED. Evaluation of exercise thallium scintigraphy versus exercise electrocardiography in predicting survival outcomes and morbid cardiac events in patients with single- and double-vessel disease. Findings from the Angioplasty Compared to Medicine (ACME) Study. J Am Coll Cardiol. 1997;30:1256 63. 334. Poldermans D, Fioretti PM, Boersma E, et al. Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: A single-center experience. Circulation. 1999;99:757 62. 335. Kamalesh M, Matorin R, Sawada S. Prognostic value of a negative stress echocardiographic study in diabetic patients. Am Heart J. 2002; 143:163 8. 336. Bjork Ingul C, Rozis E, Slordahl SA, et al. Incremental value of strain rate imaging to wall motion analysis for prediction of outcome in patients undergoing dobutamine stress echocardiography. Circulation. 2007;115:1252 9. 337. Poldermans D, Rambaldi R, Fioretti PM, et al. Prognostic value of dobutamine-atropine stress echocardiography for peri-operative and late cardiac events in patients scheduled for vascular surgery. Eur Heart J. 1997;18 Suppl D:D86 D96. 338. Shaw LJ, Eagle KA, Gersh BJ, et al. Meta-analysis of intravenous echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol. 1996;27:787 98. 339. Hachamovitch R, Berman DS, Kiat H, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol. 1997;80:426 33. 340. Lima RS, De Lorenzo A, Pantoja MR, et al. Incremental prognostic value of myocardial perfusion 99m-technetium-sestamibi SPECT in the elderly. Int J Cardiol. 2004;93:137 43. 341. Schinkel AF, Elhendy A, Biagini E, et al. Prognostic stratification using dobutamine stress 99mTc-tetrofosmin myocardial perfusion SPECT in elderly patients unable to perform exercise testing. J Nucl Med. 2005;46:12 8. 342. Rozanski A, Gransar H, Hayes SW, et al. Comparison of long-term mortality risk following normal exercise vs adenosine myocardial per- fusion SPECT. J Nucl Cardiol. 2010;17:999 1008. 343. Wallace EL, Morgan TM, Walsh TF, et al. Dobutamine cardiac magnetic resonance results predict cardiac prognosis in women with known or suspected ischemic heart disease. J Am Coll Cardiol Car- diovasc Imaging. 2009;2:299 307. 344. Cortigiani L, Picano E, Vigna C, et al. Prognostic value of pharma- cologic stress echocardiography in patients with left bundle branch block. Am J Med. 2001;110:361 9. 345. Min JK, Shaw LJ, Devereux RB, et al. Prognostic value of multide- tector coronary computed tomographic angiography for prediction of all-cause mortality. J Am Coll Cardiol. 2007;50:1161 70. 346. Small GR, Yam Y, Chen L, et al. Prognostic assessment of coronary artery bypass patients with 64-slice computed tomography angiography anatomical information is incremental to clinical risk prediction. J Am Coll Cardiol. 2011;58:2389 95. 347. Chow BJ, Ahmed O, Small G, et al. Prognostic value of CT angiography in coronary bypass patients. J Am Coll Cardiol Car- diovasc Imaging. 2011;4:496 502. 348. Hachamovitch R, Johnson JR, Hlatky MA, et al. The study of myo- cardial perfusion and coronary anatomy imaging roles in CAD (SPARC): design, rationale, and baseline patient characteristics of a prospective, multicenter observational registry comparing PET, SPECT, and CTA for resource utilization and clinical outcomes. J Nucl Cardiol. 2009;16:935 48. 349. Survivors of out-of-hospital cardiac arrest with apparently normal heart. Need for definition and standardized clinical evaluation. Con- sensus statement of the Joint Steering Committees of the Unexplained Cardiac Arrest Registry of Europe and of the Idiopathic Ventricular Fibrillation Registry of the United States. Circulation. 1997;95:265 72. 350. Every NR, Fahrenbruch CE, Hallstrom AP, et al. Influence of coronary bypass surgery on subsequent outcome of patients resuscitated from out of hospital cardiac arrest. J Am Coll Cardiol. 1992;19:1435 9. 351. Spaulding CM, Joly LM, Rosenberg A, et al. Immediate coronary angiography in survivors of out-of-hospital cardiac arrest. N Engl J Med. 1997;336:1629 33. 352. Califf RM, Harrell FE Jr, Lee KL, et al. The evolution of medical and surgical therapy for coronary artery disease. A 15-year perspective. JAMA. 1989;261:2077 86. 353. Myers WO, Schaff HV, Gersh BJ, et al. Improved survival of sur- gically treated patients with triple vessel coronary artery disease and severe angina pectoris. A report from the Coronary Artery Surgery Study (CASS) registry. J Thorac Cardiovasc Surg. 1989;97:487 95. 354. Myers WO, Gersh BJ, Fisher LD, et al. Medical versus early surgical therapy in patients with triple-vessel disease and mild angina pectoris: a CASS registry study of survival. Ann Thorac Surg. 1987;44:471 86. 355. Bonow RO, Maurer G, Lee KL, et al. Myocardial Viability and Survival in Ischemic Left Ventricular Dysfunction. N Engl J Med. 2011;364:1617 25. 356. Brunelli C, Cristofani R, L Abbate A. Long-term survival in medically treated patients with ischaemic heart disease and prognostic importance of clinical and electrocardiographic data (the Italian CNR Multicentre Prospective Study OD1). Eur Heart J. 1989;10:292 303. 357. Chuah SC, Pellikka PA, Roger VL, et al. Role of dobutamine stress echocardiography in predicting outcome in 860 patients with known or suspected coronary artery disease. Circulation. 1998;97:1474 80. Fihn et al Stable Ischemic Heart Disease: Full Text e443 358. Harris PJ, Harrell FE Jr, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259 69. 359. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7: 464 71. 360. Marwick TH, Mehta R, Arheart K, et al. Use of exercise echocardiog- raphy for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83 90. 361. Morrow K, Morris CK, Froelicher VF, et al. Prediction of cardiovas- cular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med. 1993;118:689 95. 362. Stratmann HG, Williams GA, Wittry MD, et al. Exercise technetium- 99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 1994;89:615 22. 363. Miller TD, Christian TF, Taliercio CP, et al. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ische- mia: outcome with medical therapy versus revascularization. Mayo Clin Proc. 1994;69:626 31. 364. Emond M, Mock MB, Davis KB, et al. Long-term survival of med- ically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645 57. 365. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circu- lation. 1983;68:785 95. 366. Boden WE, O Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503 16. 367. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation. 1983;68:951 60. 368. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217 25. 369. Leape LL, Park RE, Bashore TM, et al. Effect of variability in the inter- pretation of coronary angiograms on the appropriateness of use of coro- nary revascularization procedures. Am Heart J. 2000;139:106 13. 370. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myo- cardial infarction. J Am Coll Cardiol. 1988;12:56 62. 371. Little WC, Constantinescu M,Applegate RJ, et al. Can coronary angiogra- phy predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157 66. 372. Braunwald E. Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol. 2006;47:C101 C103. 373. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Adminis- tration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med. 1984;311:1333 9. 374. Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angio- graphic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest. 1983;71:1854 66. 375. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629 46. 376. Gersh BJ, Califf RM, Loop FD, et al. Coronary bypass surgery in chronic stable angina. Circulation. 1989;79:I46 I59. 377. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of ther- apy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994;89:2015 25. 377a. Snow V, Barry P, Fihn SD, et al. Evaluation of primary care patients with chronic stable angina: guidelines from the American College of Physicians. Ann Intern Med. 2004;141:57 64. 378. Califf RM, Phillips HR, III, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5:1055 63. 379. Nakagomi A, Celermajer DS, Lumley T, et al. Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. Am J Cardiol. 1996;78:516 9. 380. Campeau L, Corbara F, Crochet D, et al. Left main coronary artery stenosis: the influence of aortocoronary bypass surgery on survival. Circulation. 1978;57:1111 5. 381. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main coronary artery dis- ease. Long-term CASS experience. Circulation. 1995;91:2325 34. 382. Conley MJ, Ely RL, Kisslo J, et al. The prognostic spectrum of left main stenosis. Circulation. 1978;57:947 52. 383. Cameron A, Kemp HG Jr, Fisher LD, et al. Left main coronary artery stenosis: angiographic determination. Circulation. 1983;68:484 9. 358. Harris PJ, Harrell FE Jr, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259 69. 359. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7: 464 71. 360. Marwick TH, Mehta R, Arheart K, et al. Use of exercise echocardiog- raphy for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83 90. 361. Morrow K, Morris CK, Froelicher VF, et al. Prediction of cardiovas- cular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med. 1993;118:689 95. 362. Stratmann HG, Williams GA, Wittry MD, et al. Exercise technetium- 99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 1994;89:615 22. 363. Miller TD, Christian TF, Taliercio CP, et al. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ische- mia: outcome with medical therapy versus revascularization. Mayo Clin Proc. 1994;69:626 31. 364. Emond M, Mock MB, Davis KB, et al. Long-term survival of med- ically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645 57. 365. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circu- lation. 1983;68:785 95. 366. Boden WE, O Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503 16. 367. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation. 1983;68:951 60. 368. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217 25. 369. Leape LL, Park RE, Bashore TM, et al. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. Am Heart J. 2000;139:106 13. 370. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myo- cardial infarction. J Am Coll Cardiol. 1988;12:56 62. 371. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157 66. 372. Braunwald E. Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol. 2006;47:C101 C103. 373. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Adminis- tration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med. 1984;311:1333 9. 374. Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angio- graphic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest. 1983;71:1854 66. 375. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629 46. 376. Gersh BJ, Califf RM, Loop FD, et al. Coronary bypass surgery in chronic stable angina. Circulation. 1989;79:I46 I59. 377. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994;89:2015 25. 378. Califf RM, Phillips HR, III, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5:1055 63. 379. Nakagomi A, Celermajer DS, Lumley T, et al. Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. Am J Cardiol. 1996;78:516 9. 380. Campeau L, Corbara F, Crochet D, et al. Left main coronary artery stenosis: the influence of aortocoronary bypass surgery on survival. Circulation. 1978;57:1111 5. 381. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation. 1995;91:2325 34. 382. Conley MJ, Ely RL, Kisslo J, et al. The prognostic spectrum of left main stenosis. Circulation. 1978;57:947 52. 383. Cameron A, Kemp HG Jr, Fisher LD, et al. Left main coronary artery stenosis: angiographic determination. Circulation. 1983;68:484 9. 384. Isner JM, Kishel J, Kent KM, et al. Accuracy of angiographic deter- mination of left main coronary arterial narrowing. Angiographic histologic correlative analysis in 28 patients. Circulation. 1981;63: 1056 64. 385. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ische- mic heart disease. Circulation. 1995;92:2333 42. 386. West JN, Bennett MR, Pentecost BL. Association of transient abnormal Q-waves during exercise testing with a stenosis of the main stem of the left coronary artery. Int J Cardiol. 1991;31:102 4. 387. Gibbons RJ, Fyke FE, III, Brown ML, et al. Comparison of exercise performance in left main and three-vessel coronary artery disease. Cathet Cardiovasc Diagn. 1991;22:14 20. 388. Janosi A, Vertes A. Exercise testing and left main coronary artery stenosis. Can patients with left main disease be identified? Chest. 1991;100:227 9. 389. Morris SN, Phillips JF, Jordan JW, et al. Incidence and significance of decreases in systolic blood pressure during graded treadmill exercise testing. Am J Cardiol. 1978;41:221 6. 390. Plotnick GD, Greene HL, Carliner NH, et al. Clinical indicators of left main coronary artery disease in unstable angina. Ann Intern Med. 1979;91:149 53. 391. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980 2000. N Engl J Med. 2007;356: 2388 98. 392. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937 52. 393. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706 17. 394. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383 9. 395. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investi- gators. N Engl J Med. 1996;335:1001 9. 396. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cho- lesterol levels. The Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349 57. 397. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorva- statin versus Revascularization Treatment Investigators. N Engl J Med. 1999;341:70 6. 398. MRC-BHF Heart Protection Study of cholesterol lowering with sim- vastatin in 20,536 high-risk individuals: a randomised placebocon- trolled trial. Lancet. 2002;360:7 22. 399. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20 8. 400. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425 35. 401. Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med. 2004; 164:1427 36. 402. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489 97. 403. Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153:578 81. 404. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med. 2002;8:1257 62. 405. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997;350:461 8. 406. Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation. 2004;110:1213 8. 407. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359: 677 87. at AHA National Center on February 11, 2014 http://circ.ahajournals.org/ Downloaded from 358. Harris PJ, Harrell FE Jr, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259 69. 359. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7: 464 71. 360. Marwick TH, Mehta R, Arheart K, et al. Use of exercise echocardiog- raphy for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83 90. 361. Morrow K, Morris CK, Froelicher VF, et al. Prediction of cardiovas- cular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med. 1993;118:689 95. 362. Stratmann HG, Williams GA, Wittry MD, et al. Exercise technetium- 99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 1994;89:615 22. 363. Miller TD, Christian TF, Taliercio CP, et al. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ische- mia: outcome with medical therapy versus revascularization. Mayo Clin Proc. 1994;69:626 31. 364. Emond M, Mock MB, Davis KB, et al. Long-term survival of med- ically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645 57. 365. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circu- lation. 1983;68:785 95. 366. Boden WE, O Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356:1503 16. 367. Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups. Circulation. 1983;68:951 60. 368. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1996;335:217 25. 369. Leape LL, Park RE, Bashore TM, et al. Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. Am Heart J. 2000;139:106 13. 370. Ambrose JA, Tannenbaum MA, Alexopoulos D, et al. Angiographic progression of coronary artery disease and the development of myo- cardial infarction. J Am Coll Cardiol. 1988;12:56 62. 371. Little WC, Constantinescu M, Applegate RJ, et al. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation. 1988;78:1157 66. 372. Braunwald E. Epilogue: what do clinicians expect from imagers? J Am Coll Cardiol. 2006;47:C101 C103. 373. Eleven-year survival in the Veterans Administration randomized trial of coronary bypass surgery for stable angina. The Veterans Adminis- tration Coronary Artery Bypass Surgery Cooperative Study Group. N Engl J Med. 1984;311:1333 9. 374. Ringqvist I, Fisher LD, Mock M, et al. Prognostic value of angio- graphic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS). J Clin Invest. 1983;71:1854 66. 375. Alderman EL, Bourassa MG, Cohen LS, et al. Ten-year follow-up of survival and myocardial infarction in the randomized Coronary Artery Surgery Study. Circulation. 1990;82:1629 46. 376. Gersh BJ, Califf RM, Loop FD, et al. Coronary bypass surgery in chronic stable angina. Circulation. 1989;79:I46 I59. 377. Mark DB, Nelson CL, Califf RM, et al. Continuing evolution of therapy for coronary artery disease. Initial results from the era of coronary angioplasty. Circulation. 1994;89:2015 25. 378. Califf RM, Phillips HR, III, Hindman MC, et al. Prognostic value of a coronary artery jeopardy score. J Am Coll Cardiol. 1985;5:1055 63. 379. Nakagomi A, Celermajer DS, Lumley T, et al. Angiographic severity of coronary narrowing is a surrogate marker for the extent of coronary atherosclerosis. Am J Cardiol. 1996;78:516 9. 380. Campeau L, Corbara F, Crochet D, et al. Left main coronary artery stenosis: the influence of aortocoronary bypass surgery on survival. Circulation. 1978;57:1111 5. 381. Caracciolo EA, Davis KB, Sopko G, et al. Comparison of surgical and medical group survival in patients with left main coronary artery disease. Long-term CASS experience. Circulation. 1995;91:2325 34. 382. Conley MJ, Ely RL, Kisslo J, et al. The prognostic spectrum of left main stenosis. Circulation. 1978;57:947 52. 383. Cameron A, Kemp HG Jr, Fisher LD, et al. Left main coronary artery stenosis: angiographic determination. Circulation. 1983;68:484 9. 384. Isner JM, Kishel J, Kent KM, et al. Accuracy of angiographic deter- mination of left main coronary arterial narrowing. Angiographic histologic correlative analysis in 28 patients. Circulation. 1981;63: 1056 64. 385. Topol EJ, Nissen SE. Our preoccupation with coronary luminology. The dissociation between clinical and angiographic findings in ische- mic heart disease. Circulation. 1995;92:2333 42. 386. West JN, Bennett MR, Pentecost BL. Association of transient abnormal Q-waves during exercise testing with a stenosis of the main stem of the left coronary artery. Int J Cardiol. 1991;31:102 4. 387. Gibbons RJ, Fyke FE, III, Brown ML, et al. Comparison of exercise performance in left main and three-vessel coronary artery disease. Cathet Cardiovasc Diagn. 1991;22:14 20. 388. Janosi A, Vertes A. Exercise testing and left main coronary artery stenosis. Can patients with left main disease be identified? Chest. 1991;100:227 9. 389. Morris SN, Phillips JF, Jordan JW, et al. Incidence and significance of decreases in systolic blood pressure during graded treadmill exercise testing. Am J Cardiol. 1978;41:221 6. 390. Plotnick GD, Greene HL, Carliner NH, et al. Clinical indicators of left main coronary artery disease in unstable angina. Ann Intern Med. 1979;91:149 53. 391. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980 2000. N Engl J Med. 2007;356: 2388 98. 392. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937 52. 393. Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med. 2006;354:1706 17. 394. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383 9. 395. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investi- gators. N Engl J Med. 1996;335:1001 9. 396. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cho- lesterol levels. The Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med. 1998;339:1349 57. 397. Pitt B, Waters D, Brown WV, et al. Aggressive lipid-lowering therapy compared with angioplasty in stable coronary artery disease. Atorva- statin versus Revascularization Treatment Investigators. N Engl J Med. 1999;341:70 6. 398. MRC-BHF Heart Protection Study of cholesterol lowering with sim- vastatin in 20,536 high-risk individuals: a randomised placebocon- trolled trial. Lancet. 2002;360:7 22. 399. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005;352:20 8. 400. LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med. 2005;352:1425 35. 401. Wilt TJ, Bloomfield HE, MacDonald R, et al. Effectiveness of statin therapy in adults with coronary heart disease. Arch Intern Med. 2004; 164:1427 36. 402. Gottlieb SS, McCarter RJ, Vogel RA. Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction. N Engl J Med. 1998;339:489 97. 403. Hebert PR, Moser M, Mayer J, et al. Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease. Arch Intern Med. 1993;153:578 81. 404. Libby P, Aikawa M. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets. Nat Med. 2002;8:1257 62. 405. Coronary angioplasty versus medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. RITA-2 trial participants. Lancet. 1997;350:461 8. 406. Pfisterer M. Long-term outcome in elderly patients with chronic angina managed invasively versus by optimized medical therapy: four-year follow-up of the randomized Trial of Invasive versus Medical therapy in Elderly patients (TIME). Circulation. 2004;110:1213 8. 407. Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359: 677 87. at AHA National Center on February 11, 2014 http://circ.ahajournals.org/ Downloaded from 358. Harris PJ, Harrell FE Jr, Lee KL, et al. Survival in medically treated coronary artery disease. Circulation. 1979;60:1259 69. 359. Ladenheim ML, Pollock BH, Rozanski A, et al. Extent and severity of myocardial hypoperfusion as predictors of prognosis in patients with suspected coronary artery disease. J Am Coll Cardiol. 1986;7: 464 71. 360. Marwick TH, Mehta R, Arheart K, et al. Use of exercise echocardiog- raphy for prognostic evaluation of patients with known or suspected coronary artery disease. J Am Coll Cardiol. 1997;30:83 90. 361. Morrow K, Morris CK, Froelicher VF, et al. Prediction of cardiovas- cular death in men undergoing noninvasive evaluation for coronary artery disease. Ann Intern Med. 1993;118:689 95. 362. Stratmann HG, Williams GA, Wittry MD, et al. Exercise technetium- 99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation. 1994;89:615 22. 363. Miller TD, Christian TF, Taliercio CP, et al. Impaired left ventricular function, one- or two-vessel coronary artery disease, and severe ische- mia: outcome with medical therapy versus revascularization. Mayo Clin Proc. 1994;69:626 31. 364. Emond M, Mock MB, Davis KB, et al. Long-term survival of med- ically treated patients in the Coronary Artery Surgery Study (CASS) Registry. Circulation. 1994;90:2645 57. 365. Alderman EL, Fisher LD, Litwin P, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circu- lation. 1983;68:785 95. 366. Boden WE, O Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. 